New medications to help with fluid buildup when current diuretics stop working
Preclinical validation of Kir4.1/5.1 inhibitors for overcoming diuretic resistance
This research is developing new medications to help patients with heart failure, kidney disease, or liver disease who experience fluid buildup that doesn't respond to standard diuretic treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University Medical Center NIH-funded |
| Lab location | 1 site (Nashville, United States) |
| Project ID | NIH-11137816 on NIH RePORTER |
What this research studies
Many patients with conditions like heart failure, kidney disease, or liver disease experience uncomfortable and dangerous fluid buildup, called edema. While common medications called loop diuretics often help, over time, the body can adapt, making these drugs less effective. This project aims to find new ways to help the body get rid of excess fluid by targeting specific channels in the kidneys. We are working to develop and test new medications that could overcome this resistance, offering a new option for patients when current treatments are no longer enough.
Who could benefit from this research
Good fit: This research is focused on developing treatments for patients with congestive heart failure, chronic kidney disease, or chronic liver disease who experience diuretic resistance and persistent fluid buildup.
Not a fit: Patients who do not experience fluid retention or whose fluid retention responds well to current diuretic therapies may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this research could lead to new and more effective treatments for patients suffering from fluid retention due to heart, kidney, or liver conditions, especially when existing diuretics are no longer working well.
How similar studies have performed: This approach explores a novel mechanism for diuretic action, building on a decade of emerging understanding of Kir4.1/5.1 channels, suggesting it is a new and untested strategy.
Where this research is happening
Nashville, United States
- Vanderbilt University Medical Center — Nashville, United States (Active)
Researchers
- Principal investigator: Denton, Jerod S. — Vanderbilt University Medical Center
- Study coordinator: Denton, Jerod S.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.